Welcome to our dedicated page for Ehealth SEC filings (Ticker: EHTH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The eHealth, Inc. (NASDAQ: EHTH) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a public company in the insurance agencies and brokerages industry, eHealth uses SEC filings to report material events, financial results, governance changes, and capital structure developments that are relevant to investors evaluating EHTH stock.
eHealth regularly files current reports on Form 8-K to announce significant developments. Recent 8-K filings describe quarterly financial results, including press releases for the second and third quarters of a fiscal year, and provide information about the company’s financial condition. Other 8-Ks document amendments to credit agreements, such as an extension of the maturity date of a term loan credit agreement with Blue Torch Finance LLC and the entry into a new asset-based revolving credit facility with Manulife | Comvest Credit Partners, along with the use of proceeds to repay existing debt and support strategic initiatives.
Filings also address corporate governance and compensation matters. eHealth has reported on amendments and restatements of its bylaws, including changes to meeting notice deadlines, definitions relevant to principal competitors, and provisions related to indemnification and insurance for directors, officers, employees and agents. Other filings discuss the approval and amendment of equity incentive plans, inducement and equity awards for executives and directors, and the results of stockholder votes on director elections, executive compensation, and plan amendments.
Leadership changes and board composition are another focus of eHealth’s SEC reports. Form 8-K filings describe CEO transition arrangements, the appointment of a new chief executive officer, related severance and compensation agreements, and the resignation and appointment of directors, including those designated under an investment agreement with a preferred stock investor. These disclosures help investors understand how management and board oversight are evolving.
On Stock Titan, eHealth’s SEC filings are paired with AI-powered summaries that help explain the contents of lengthy documents such as 8-Ks and, where available, annual reports on Form 10-K, quarterly reports on Form 10-Q, and proxy statements. Real-time updates from EDGAR ensure that new filings, including any insider transaction reports on Form 4 or other material disclosures, are quickly reflected. The AI summaries highlight key points, such as changes in capital structure, governance updates, and important risk or operational information, allowing users to review the implications for EHTH without reading every line of each filing.
By using this filings page, investors can efficiently review eHealth’s regulatory history, track recurring themes in its disclosures, and connect filing information with the company’s news releases and business description. This context can support deeper analysis of eHealth’s financial performance, risk profile, and strategic direction as presented in its official SEC documents.
eHealth, Inc. announced that director Andrea C. Brimmer will not stand for re-election and will leave the Board when her current term ends at the 2026 annual meeting on June 18, 2026. The company stated that her decision does not reflect any disagreement over operations, policies, or practices.
Brimmer has served on the Board for nearly eight years, and both she and CEO Derrick Duke emphasized appreciation for her contributions and continued support for eHealth’s mission. eHealth describes itself as a leading independent online health insurance marketplace, offering access to over 180 health insurers across the United States.
eHealth, Inc. Chief Financial Officer John Joseph Dolan reported an acquisition of 73,500 performance-based restricted stock units (PSUs) that were earned after the compensation committee certified performance for awards granted in April 2024 and October 2024. Each PSU represents a contingent right to receive one share of common stock upon vesting, scheduled for December 31, 2026, as long as he continues providing services through that date. After this award, his reported common stock holdings stand at 282,255 shares held directly, reflecting a compensation-related equity grant rather than an open-market purchase.
Galimi Gavin G. reported acquisition or exercise transactions in this Form 4 filing.
eHealth, Inc. reported that SVP, General Counsel & Secretary Gavin G. Galimi received a grant of 59,500 performance-based restricted stock units (PSUs) as a share award, not through an open-market purchase. These PSUs were earned after the compensation committee certified achievement of performance criteria from awards granted on April 5, 2024.
Each PSU represents a contingent right to receive one share of common stock, scheduled to vest on December 31, 2026, if he continues providing services through that date. Following this grant, he holds 288,197 shares of common stock directly.
eHealth, Inc. Chief Revenue Officer Michelle Marie Barbeau reported an acquisition of 70,000 shares of common stock through the earning of performance-based restricted stock units. These PSUs were earned after the Compensation Committee certified performance for awards granted on April 5, 2024.
Each PSU represents a right to receive one share of common stock upon vesting. The PSUs are scheduled to vest on December 31, 2026, if she continues providing services through that date. Following this grant, she directly holds 312,988 shares.
eHealth, Inc. director Francis S. Soistman Jr. reported an acquisition of 250,000 shares of common stock at a price of $0.00 per share. According to the footnote, this represents performance-based restricted stock units (PSUs) earned under awards granted on April 5, 2024, with each PSU corresponding to one share of common stock upon vesting. The PSUs are scheduled to vest on December 31, 2026, assuming he continues providing services through that date. Following this award, his directly held common stock position reported in the filing is 1,028,773 shares.
eHealth, Inc. senior vice president and general counsel Gavin G. Galimi reported a routine tax-related share withholding. On this Form 4, 2,045 shares of common stock were withheld at $1.62 per share to satisfy tax obligations.
After this tax-withholding disposition, Galimi beneficially owns 228,697 shares of eHealth common stock directly. This event reflects compensation-related tax settlement rather than an open-market purchase or sale.
eHealth, Inc. Chief Revenue Officer Michelle Marie Barbeau reported a routine tax-related share disposition. On March 10, she had 5,058 shares of common stock withheld at $1.62 per share to satisfy tax obligations, rather than selling them on the open market. After this withholding, she directly holds 242,988 shares of eHealth common stock.
eHealth, Inc. Chief Financial Officer John Joseph Dolan reported an open-market purchase of 25,000 shares of common stock on March 6, 2026. The weighted average purchase price was $1.5276 per share, with individual trades executed between $1.515 and $1.530. Following this transaction, Dolan directly owns 208,755 shares of eHealth common stock.
eHealth, Inc. director and Chief Executive Officer Derrick A. Duke reported an open-market purchase of 187,969 shares of common stock at $1.38 per share on February 27, 2026. Following this transaction, he directly owns 487,969 shares of eHealth common stock.